nimesulide
Sponsors
Novartis Pharmaceuticals, European Institute of Oncology, Boehringer Ingelheim, Pomeranian Medical University Szczecin
Conditions
Breast CancerPharyngitisTemporomandibular Joint DisordersTemporomandibular Joint Dysfunction SyndromeTemporomandibular Joint PainUpper Respiratory Tract Infections
Phase 2
A Prevention Trial in Subjects at High Risk for Breast Cancer
CompletedNCT01500577
Start: 2005-04-30End: 2013-07-31Updated: 2014-06-18
Comparative Analysis of the Effectiveness of the Use of Nimesulide and CBD Oil in Patients With Pain in the Preauricular Region Due to the Pain-dysfunctional Syndrome of the Temporomandibular Joint.
NCT04609748
Start: 2021-01-27End: 2021-12-31Target: 30Updated: 2021-01-29
Phase 4
Efficacy of Diclofenac Potassium vs Nimesulide in the Treatment of Fever and Pain in Children With Upper Respiratory Tract Infection
WithdrawnNCT01257126
Start: 2011-04-30Updated: 2012-04-26
Efficacy and Safety of Meloxicam Suspension Versus Diclofenac Suspension or Nimesulide Suspension in Patients With a Diagnosis of Acute, Non-bacterial Pharyngitis, Pharyngotonsillitis or Laryngitis
CompletedNCT02229747
Start: 2001-08-31Updated: 2014-09-01